Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Oct 30;52(5):2193-2201.
doi: 10.1042/BST20240242.

Hetero-oligomeric interaction as a new regulatory mechanism for protein arginine methyltransferases

Affiliations
Review

Hetero-oligomeric interaction as a new regulatory mechanism for protein arginine methyltransferases

Angela A Bae et al. Biochem Soc Trans. .

Abstract

Protein arginine methylation is a versatile post-translational protein modification that has notable cellular roles such as transcriptional activation or repression, cell signaling, cell cycle regulation, and DNA damage response. However, in spite of their extensive significance in the biological system, there is still a significant gap in understanding of the entire function of the protein arginine methyltransferases (PRMTs). It has been well-established that PRMTs form homo-oligomeric complexes to be catalytically active, but in recent years, several studies have showcased evidence that different members of PRMTs can have cross-talk with one another to form hetero-oligomeric complexes. Additionally, these heteromeric complexes have distinct roles separate from their homomeric counterparts. Here, we review and highlight the discovery of the heterodimerization of PRMTs and discuss the biological implications of these hetero-oligomeric interactions.

Keywords: PRMTs; arginine methylation; cross-talk; hetero-oligomeric complex; protein–protein interactions; regulation.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no competing interests associated with the manuscript.

Similar articles

Cited by

References

    1. Fulton MD, Brown T and Zheng YG (2018) Mechanisms and inhibitors of histone arginine methylation. Chem. Rec 18, 1792–1807 10.1002/tcr.201800082 - DOI - PMC - PubMed
    1. Hwang JW, Cho Y, Bae GU, Kim SN and Kim YK (2021) Protein arginine methyltransferases: promising targets for cancer therapy. Exp. Mol Med 53, 788–808 10.1038/s12276-021-00613-y - DOI - PMC - PubMed
    1. Tewary SK, Zheng YG and Ho MC (2019) Protein arginine methyltransferases: insights into the enzyme structure and mechanism at the atomic level. Cell. Mol. Life Sci 76, 2917–2932 10.1007/s00018-019-03145-x - DOI - PMC - PubMed
    1. Bedford MT and Clarke SG (2009) Protein arginine methylation in mammals: who, what, and why. Mol. Cell 33, 1–13 10.1016/j.molcel.2008.12.013 - DOI - PMC - PubMed
    1. Yang Y and Bedford MT (2013) Protein arginine methyltransferases and cancer. Nat. Rev. Cancer 13, 37–50 10.1038/nrc3409 - DOI - PubMed

Publication types

Substances

LinkOut - more resources